Inotiv (NOTV) Statistics

Inotiv, Inc. (NOTV) is a company that specializes in providing contract research services to pharmaceutical, biotechnology, and medical device companies. As of the most recent statistics, the stock has a market capitalization of $XXX million and a trading volume of XXX shares. The stock's average daily trading volume is XXX shares, indicating a high level of liquidity. With a price-to-earnings (P/E) ratio of XX.XX, the stock is considered to be fairly valued in relation to its earnings. The company's earnings per share (EPS) is $XX.XX, reflecting its profitability and ability to generate revenue for shareholders.

In terms of valuation metrics, Inotiv, Inc. has a price-to-sales (P/S) ratio of X.XX, indicating that investors are willing to pay X.XX times the company's revenue for a single share of stock. The stock's price-to-book (P/B) ratio is X.XX, suggesting that the company's assets are valued at X.XX times their book value. Additionally, the company has an enterprise value-to-EBITDA (EV/EBITDA) ratio of X.XX, which shows the multiple of earnings before interest, taxes, depreciation, and amortization that investors are willing to pay for the company. This ratio is often used to gauge the company's overall financial health and profitability.